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Dear Prof. Klein 
 
Corticosteroid use is common with 8.4 million UK prescriptions for oral preparations in 2018[1].  
They are prescribed as replacement for deficiency as well as therapeutically for a range of 
conditions.  There is no question that those on replacement corticosteroids (e.g. for pituitary / 
adrenal disease) need additional peri-operative dosing, but there are uncertainties as to which 
patients on therapeutic corticosteroids (e.g. for COPD, inflammatory arthritides) should receive 
supplementation, as well as the optimal dose. Up to one-third of patients on therapeutic 
corticosteroids show evidence of adrenal suppression when well[2]; in theory these patients could 
be unable to increase endogenous production to cover surgical stress.  No robust evidence-based 
guidelines exist currently –  recently published national consensus guidance is based on little class A 
and B evidence[3]. 
 
We hypothesised that UK clinical practice was likely to be extremely variable prior to publication of 
the guidance and this insight would help optimise future study designs to address the most 
important uncertainties. We conducted an electronic survey (SurveyMonkey ©) of the 
perioperative prescribing practices of 18,203 Royal College of Anaesthetists (RCoA) Fellows / 
Members to those taking therapeutic corticosteroids.  Formal Ethics Committee approval was not 
required as this did not fulfil current definitions of research. 
 
The survey was open between 23rd September and 23rd October 2019. 1415/18,203 (8%) fully / 
partially completed questionnaires were received.  Most respondents were Consultant 
Anaesthetists (1012/1415; 71.5%) from 13 NHS regions.  Table 1 shows the initial approach to 
prescribing. More detailed prescribing practices can be found in the supplementary material[4].   
The majority (1266/1329; 95%) prescribed perioperative steroid and most (675/1226; 55%) used 
10mg prednisolone daily as their prescribing threshold.  Few stated they would prescribe additional 
steroid to those on topical (37/1226; 3%) or inhaled (68/1226; 6%) steroids.  Most did not test pre-
operatively for adrenal suppression (1141/1226; 93%).  41% of respondents (499/1226) used 
moderate surgery (e.g. laparoscopic cholecystectomy) as the threshold for additional 
supplementation. The majority (1046/1079; 97%) chose to give an induction steroid dose; 100mg 
hydrocortisone was the most common dose (472/1079; 44%).  Importantly, there was no consensus 
on dosing, frequency or post-operative duration.   
 
This is the first national survey characterising perioperative corticosteroid prescribing practice for 
patients on therapeutic corticosteroids.  The survey suggests that both patient and procedural 
factors guided prescribing decisions, but with substantial practice variation. The absence of 
consensus prior to guideline publication is a reflection of the lack of high-quality evidence.  
 
The strength of our survey is the high proportion of Consultant Anaesthetist replies from all over 
the UK – making it likely to be a good snapshot of UK practice. The main limitation is the low 
absolute response rate - in part due to the means of dissemination.  There are around 8,000 
Consultant Anaesthetists currently practising in the UK and therefore the true response rate of 
Consultants is likely to be higher than the absolute rate appears. RCoA mailing lists hold addresses 
for current and retired anaesthetists as well as a number no longer practising / practising abroad. 
The individuals who responded were also more likely to have an interest in peri-operative care and 
corticosteroids and therefore there may be some degree of reporting bias. 
 
Very few UK anaesthetists were prescribing corticosteroids in a similar regimen to that which was 
contained in the subsequent guidance [3]. They appeared to have a higher threshold (daily 
corticosteroid dose) and prescribed lower supplementary doses. This variation before guideline 
publication can be explained in part by the lack of high-quality evidence to guide clinical decision 
making and time will be needed for the new guidance to embed before establishing if it has 
reduced practice variation. The survey provides a basis on which high-quality RCTs that test 
different therapeutic regimens can be designed. 
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Table 1: General approach to perioperative steroid management 
 
Number of 
respondents Percentage (%) 
Threshold therapeutic steroid dose for prescribing additional perioperative steroid (1226/1415 responses – rate 87%) 
5mg prednisolone or higher 329 26.8 
10mg prednisolone or higher 675 55.1 
20mg prednisolone or higher 103 8.4 
Other 119 9.7 
 
Which route of therapeutic steroid would make you prescribe additional steroid? (1226/1415 responses – rate 87%) 
Oral 977 79.7 
Topical 37 3 
Inhaled 68 5.6 
Intravenous 1077 87.9 
Intramuscular 583 47.6 
None of the above 5 0.4 
 
What duration of therapeutic steroid would make you prescribe additional steroid? (1226/1415 responses – rate 87%) 
Any length of time (even one dose) 82 6.7 
One week or more 258 21 
One month or more 482 39.3 
Three months or more 288 23.5 
Six months or more 47 3.8 
Twelve months or more 6 0.5 
Other (not specified) 63 5.1 
 
What test do you perform to assess adrenal suppression? (1226/1415 responses – rate 87%) 
No test 1141 93.1 
Random or 9am cortisol 8 0.7 
Short Synacthen test 31 2.5 
Short synacthen test and a serum cortisol 29 2.4 
Other 17 1.4 
 
What type of surgery would make you prescribe additional steroid? (1226/1415 responses – rate 87%) 
Any procedure (local and general anaesthesia) 61 5 
Any procedure under general anaesthesia 284 23.2 
Minor (e.g. hernia), moderate (e.g. Lap cholecystectomy) and major (e.g. CABG, 
joint replacement) 248 20.2 
Moderate (e.g. Lap cholecystectomy) and major (e.g. CABG, joint replacement) 499 40.7 
Major surgery (e.g. CABG, joint replacement) only 134 10.9 
 
What induction dose of steroid do you give? (1079/1415 responses – rate 76%) 
Don't give one 33 3.1 
25mg hydrocortisone 316 29.3 
75mg hydrocortisone 23 2.1 
100mg hydrocortisone 472 43.7 
Other dose or different drug 235 21.8 
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